GRP
KRYS icon

Global Retirement Partners’s Krystal Biotech KRYS Stock Holding History

Global Retirement Partners’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Buy
+519
New +$155K ﹤0.01% 1604
2025
Q4 		$39.4K Buy
160
+142
+789% +$29.9K ﹤0.01% 2490
2025
Q3 		$3.18K Buy
18
+7
+64% +$1.05K ﹤0.01% 3148
2025
Q2 		$1.51K Buy
+11
New +$1.62K ﹤0.01% 3333
2023
Q2 		– Sell
-125
Closed -$10.5K – 3227
2023
Q1 		$10.5K Hold
125
– – ﹤0.01% 1909
2022
Q4 		$9.9K Hold
125
– – ﹤0.01% 1786
2022
Q3 		$10K Hold
125
– – ﹤0.01% 1687
2022
Q2 		$8K Hold
125
– – ﹤0.01% 1734
2022
Q1 		$7K Buy
+125
New +$7.8K ﹤0.01% 1777
2021
Q4 		– Sell
-125
Closed -$7K – 1100
2021
Q3 		$7K Hold
125
– – ﹤0.01% 1525
2021
Q2 		$9K Sell
125
-75
-38% -$5.24K ﹤0.01% 1401
2021
Q1 		$15K Buy
200
+75
+60% +$5.45K ﹤0.01% 1187
2020
Q4 		$8K Buy
+125
New +$6.24K ﹤0.01% 1323

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Global Retirement Partners's KRYS Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Krystal Biotech (KRYS) in Q2 2026: 519 shares worth $193K. The stake represents ﹤0.01% of the portfolio and ranks #1604 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in KRYS as recently as Q4 2025.

Global Retirement Partners first reported a position in KRYS in Q4 2020 and has held it in 13 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Global Retirement Partners held 519 shares of Krystal Biotech worth $193K as of Q2 2026.
  • Krystal Biotech was a new Global Retirement Partners position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1604 holding.
  • Global Retirement Partners first reported a position in Krystal Biotech in Q4 2020 and has held it in 13 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.